• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠乳腺肿瘤细胞系MMT060562可产生前列腺素E2和白血病抑制因子,并通过基质细胞依赖性途径在体外支持破骨细胞的形成。

The mouse mammary tumor cell line, MMT060562, produces prostaglandin E2 and leukemia inhibitory factor and supports osteoclast formation in vitro via a stromal cell-dependent pathway.

作者信息

Akatsu T, Ono K, Katayama Y, Tamura T, Nishikawa M, Kugai N, Yamamoto M, Nagata N

机构信息

The Third Department of Internal Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan.

出版信息

J Bone Miner Res. 1998 Mar;13(3):400-8. doi: 10.1359/jbmr.1998.13.3.400.

DOI:10.1359/jbmr.1998.13.3.400
PMID:9525340
Abstract

Osteoclastic bone resorption increases at the site of bone metastasis, but little is known about how tumor cells induce osteoclast (OC) recruitment in the bone marrow microenvironment. To clarify this point, we examined the effects of various mouse tumor cells on OC recruitment using cocultures of tumor cells and mouse marrow cells. The mouse mammary tumor cell lines, MMT060562 (MMT), BALB/c-MC, Jyg-MC(A), or other nonmammary tumor cell lines, LLC and B16, were cocultured with mouse marrow cells, and OC recruitment from marrow cells was determined by counting the number of tartrate-resistant acid phosphatase-positive multinucleated cells (TRAP(+) MNCs) formed. Of the tumor cells examined, MMT and BALB/c-MC stimulated OC formation, but other tumor cells did not. OC formation with MMT was dependent on the number of MMTs inoculated, and only ten cells per well were sufficient to induce OC development. OCs appeared on day 4, and the number reached a maximum on days 5-8 and decreased thereafter. TRAP(+) MNCs induced by MMT satisfied the major criteria of OCs, such as the presence of calcitonin receptors and the ability to resorb calcified tissues. The majority of OCs were formed adjacent to the stromal cells, which were positive for alkaline phosphatase. When spleen cells were cocultured with MMT, no OCs were formed. In contrast, when osteoblastic cells were added to cocultures of spleen cells and MMT, many OCs were formed. The cultured media (CM) of MMT induced OC formation in mouse marrow cultures. Neither parathyroid hormone-like nor interleukin 1-like activity was present in the CM. MMT constitutively produced prostaglandin E2 (PGE2) and OC formation in cocultures was completely inhibited by indomethacin. Fractionation of the CM of MMT by ultrafiltration indicated that the OC-inducing activities were present not only in the fraction with molecular weight below 3 kDa but also in the fraction with molecular weight above 3 kDa. OC-inducing activity with high molecular weight was eluted around 50 kDa by Bio-Gel P-60 column chromatography. The active fractions also possessed leukemia inhibitory factor (LIF) activity, and OC-inducing activity of the peak fraction was inhibited in the presence of anti-LIF neutralizing antibody. The results of this study indicated that MMTs release PGE2 and LIF, which in turn stimulate OC formation via a stromal cell-dependent pathway. These culture systems will help to clarify the mechanisms by which tumor cells induce OC formation in a bone marrow microenvironment.

摘要

在骨转移部位破骨细胞介导的骨吸收增加,但关于肿瘤细胞如何在骨髓微环境中诱导破骨细胞(OC)募集却知之甚少。为阐明这一点,我们使用肿瘤细胞与小鼠骨髓细胞共培养的方法,研究了各种小鼠肿瘤细胞对OC募集的影响。将小鼠乳腺肿瘤细胞系MMT060562(MMT)、BALB/c-MC、Jyg-MC(A),或其他非乳腺肿瘤细胞系LLC和B16与小鼠骨髓细胞共培养,通过计数形成的抗酒石酸酸性磷酸酶阳性多核细胞(TRAP(+) MNCs)数量来确定骨髓细胞中OC的募集情况。在所检测的肿瘤细胞中,MMT和BALB/c-MC刺激了OC形成,而其他肿瘤细胞则没有。MMT诱导的OC形成取决于接种的MMT数量,每孔仅10个细胞就足以诱导OC发育。OC在第4天出现,数量在第5 - 8天达到最大值,此后减少。MMT诱导的TRAP(+) MNCs满足OC的主要标准,如存在降钙素受体和吸收钙化组织的能力。大多数OC在碱性磷酸酶阳性的基质细胞附近形成。当脾细胞与MMT共培养时,未形成OC。相反,当将成骨细胞添加到脾细胞与MMT的共培养体系中时,形成了许多OC。MMT的培养基(CM)在小鼠骨髓培养中诱导OC形成。CM中不存在甲状旁腺激素样或白细胞介素1样活性。MMT持续产生前列腺素E2(PGE2),共培养中OC的形成被吲哚美辛完全抑制。通过超滤对MMT的CM进行分级分离表明,OC诱导活性不仅存在于分子量低于3 kDa的组分中,也存在于分子量高于3 kDa的组分中。通过Bio-Gel P - 60柱色谱法,高分子量的OC诱导活性在约50 kDa处被洗脱。活性组分还具有白血病抑制因子(LIF)活性,并且在存在抗LIF中和抗体的情况下,峰值组分的OC诱导活性受到抑制。本研究结果表明,MMT释放PGE2和LIF,进而通过基质细胞依赖途径刺激OC形成。这些培养系统将有助于阐明肿瘤细胞在骨髓微环境中诱导OC形成的机制。

相似文献

1
The mouse mammary tumor cell line, MMT060562, produces prostaglandin E2 and leukemia inhibitory factor and supports osteoclast formation in vitro via a stromal cell-dependent pathway.小鼠乳腺肿瘤细胞系MMT060562可产生前列腺素E2和白血病抑制因子,并通过基质细胞依赖性途径在体外支持破骨细胞的形成。
J Bone Miner Res. 1998 Mar;13(3):400-8. doi: 10.1359/jbmr.1998.13.3.400.
2
Chinese hamster ovary cells expressing alpha4beta1 integrin stimulate osteoclast formation in vitro.表达α4β1整合素的中国仓鼠卵巢细胞在体外刺激破骨细胞形成。
J Bone Miner Res. 1998 Aug;13(8):1251-9. doi: 10.1359/jbmr.1998.13.8.1251.
3
Mouse mammary carcinoma cell line (BALB/c-MC) stimulates osteoclast formation from mouse bone marrow cells through cell-to-cell contact.小鼠乳腺癌细胞系(BALB/c-MC)通过细胞间接触刺激小鼠骨髓细胞形成破骨细胞。
Bone. 1998 Jul;23(1):27-32. doi: 10.1016/s8756-3282(98)00065-9.
4
Estrogen blocks parathyroid hormone-stimulated osteoclast-like cell formation in modulating differentiation of mouse marrow stromal cells in vitro.雌激素在体外调节小鼠骨髓基质细胞分化过程中可阻断甲状旁腺激素刺激的破骨细胞样细胞形成。
J Formos Med Assoc. 2002 Jan;101(1):24-33.
5
Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.降钙素受体在骨髓细胞培养物及骨骼中的表达:一种受降钙素调节的分化破骨细胞的特异性标志物。
Endocrinology. 1995 Oct;136(10):4572-81. doi: 10.1210/endo.136.10.7664679.
6
Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.在新建立的人类神经母细胞瘤模型中,核因子κB受体活化因子配体(RANKL)是破骨细胞形成导致骨转移的关键分子。
Cancer Res. 2001 Feb 15;61(4):1637-44.
7
Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of time.在短时间内在颅骨细胞上分化为破骨细胞的破骨细胞前体的分离与鉴定。
J Cell Physiol. 1998 Oct;177(1):26-35. doi: 10.1002/(SICI)1097-4652(199810)177:1<26::AID-JCP3>3.0.CO;2-G.
8
Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines.环氧化酶-2在乳腺癌细胞系骨转移中破骨细胞形成和骨破坏中的作用。
J Bone Miner Res. 2002 May;17(5):774-81. doi: 10.1359/jbmr.2002.17.5.774.
9
Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone.小鼠制瘤素M、白血病抑制因子、心肌营养素-1和白细胞介素6在体外对破骨细胞分化的刺激作用:与地塞米松的协同作用。
Cytokine. 2000 Jun;12(6):613-21. doi: 10.1006/cyto.1999.0635.
10
Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro.敲除小鼠前列腺素EP2受体可损害体外破骨细胞生成。
Endocrinology. 2000 Jun;141(6):2054-61. doi: 10.1210/endo.141.6.7518.

引用本文的文献

1
Tumor-Specific Immunoenhancing Effects after Local Cryoablation for Metastatic Bone Tumor in a Mouse Model.肿瘤特异性免疫增强作用后局部冷冻消融治疗转移性骨肿瘤的小鼠模型。
Int J Mol Sci. 2022 Aug 21;23(16):9445. doi: 10.3390/ijms23169445.
2
Abscopal Effect of Frozen Autograft Reconstruction Combined with an Immune Checkpoint Inhibitor Analyzed Using a Metastatic Bone Tumor Model.冷冻同种异体骨重建联合免疫检查点抑制剂治疗转移性骨肿瘤模型的远隔效应分析。
Int J Mol Sci. 2021 Feb 17;22(4):1973. doi: 10.3390/ijms22041973.
3
The emerging role of leukemia inhibitory factor in cancer and therapy.
白血病抑制因子在癌症和治疗中的新作用。
Pharmacol Ther. 2021 May;221:107754. doi: 10.1016/j.pharmthera.2020.107754. Epub 2020 Nov 28.
4
EO771, is it a well-characterized cell line for mouse mammary cancer model? Limit and uncertainty.EO771,它是一种用于小鼠乳腺癌模型的特征明确的细胞系吗?局限性和不确定性。
Cancer Med. 2020 Nov;9(21):8074-8085. doi: 10.1002/cam4.3295. Epub 2020 Oct 7.
5
New functional degradable and bio-compatible nanoparticles based on poly(malic acid) derivatives for site-specific anti-cancer drug delivery.基于聚(苹果酸)衍生物的新型功能可降解和生物相容的纳米粒子,用于肿瘤部位特异性抗癌药物递送。
Int J Pharm. 2012 Feb 14;423(1):84-92. doi: 10.1016/j.ijpharm.2011.04.035. Epub 2011 Apr 27.
6
Cellular mechanisms of bone resorption in breast carcinoma.乳腺癌骨吸收的细胞机制。
Br J Cancer. 2001 Jul 6;85(1):78-84. doi: 10.1054/bjoc.2001.1856.